The August 19 issue of JNCI features articles on hepatitis B virus genotypes and the risk of liver cancer, extended follow-up data for a prostate cancer trial, data on breast cancer recurrence after adjuvant therapy, possible treatments for cancer-related fatigue, antitumor effects of doxorubicin followed by zoledronic acid, and the incidence of adenocarcinoma of the esophagus among white Americans.
